학술논문
A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis
Document Type
Article
Source
In: Cancer Chemotherapy and Pharmacology . (Cancer Chemotherapy and Pharmacology, September 2021, 88(3):415-425)
Subject
Language
English
ISSN
14320843
03445704
03445704